These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 19779706)
1. Calcium oxalate stone and gout. Marickar YM Urol Res; 2009 Dec; 37(6):345-7. PubMed ID: 19779706 [TBL] [Abstract][Full Text] [Related]
2. Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis. Pak CY; Moe OW; Sakhaee K; Peterson RD; Poindexter JR J Urol; 2005 May; 173(5):1606-9. PubMed ID: 15821508 [TBL] [Abstract][Full Text] [Related]
3. [Diagnostic values of urinary citrate for kidney stones in patients with primary gout]. Wang Y; Zhang HM; Deng XR; Liu WW; Chen L; Zhao N; Zhang XH; Song ZB; Geng Y; Ji LL; Wang Y; Zhang ZL Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1134-1140. PubMed ID: 36533345 [TBL] [Abstract][Full Text] [Related]
4. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization. Kalaiselvi P; Udayapriya KL; Selvam R BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229 [TBL] [Abstract][Full Text] [Related]
5. [The influence of uric acid on the calcium oxalate stone formation (author's transl)]. Matouschek E; Huber R Urologe A; 1979 Jul; 18(4):211-4. PubMed ID: 38552 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the metabolic profile of mixed calcium oxalate/uric acid stone formers to that of pure calcium oxalate and pure uric acid stone formers. Friedlander JI; Moreira DM; Hartman C; Elsamra SE; Smith AD; Okeke Z Urology; 2014 Aug; 84(2):289-94. PubMed ID: 24929942 [TBL] [Abstract][Full Text] [Related]
7. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Pak CY; Poindexter JR; Peterson RD; Koska J; Sakhaee K Urology; 2002 Nov; 60(5):789-94. PubMed ID: 12429297 [TBL] [Abstract][Full Text] [Related]
8. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers. Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420 [TBL] [Abstract][Full Text] [Related]
9. Gout, stone composition and urinary stone risk: a matched case comparative study. Marchini GS; Sarkissian C; Tian D; Gebreselassie S; Monga M J Urol; 2013 Apr; 189(4):1334-9. PubMed ID: 23022002 [TBL] [Abstract][Full Text] [Related]
10. The role of overweight and obesity in calcium oxalate stone formation. Siener R; Glatz S; Nicolay C; Hesse A Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848 [TBL] [Abstract][Full Text] [Related]
11. Female stone disease: the changing trend. Marickar YM; Vijay A Urol Res; 2009 Dec; 37(6):337-40. PubMed ID: 19779708 [TBL] [Abstract][Full Text] [Related]
12. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation. Schwille PO; Schmiedl A; Wipplinger J Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of factors involved in calcium stone formation. Abraham PA; Smith CL Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051 [TBL] [Abstract][Full Text] [Related]
14. The most important metabolic risk factors in recurrent urinary stone formers. Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S Urol J; 2011; 8(2):99-106. PubMed ID: 21656467 [TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation. Khatchadourian J; Preminger GM; Whitson PA; Adams-Huet B; Pak CY J Urol; 1995 Nov; 154(5):1665-9. PubMed ID: 7563316 [TBL] [Abstract][Full Text] [Related]
16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
17. Comparison of metabolic parameters between pure-uric acid and mixed-uric acid kidney stone formers. Ricapito A; Gupta K; Zipkin J; Yim S; Connors C; Khargi R; Yaghoubian AJ; Khusid JA; Atallah WM; Gupta M World J Urol; 2024 Mar; 42(1):138. PubMed ID: 38478092 [TBL] [Abstract][Full Text] [Related]
18. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers. Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589 [TBL] [Abstract][Full Text] [Related]
19. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein. Schwille PO; Schmiedl A; Manoharan M Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561 [TBL] [Abstract][Full Text] [Related]
20. Who makes uric acid stones and why--observations from a renal stones clinic. Stansbridge EM; Griffin DG; Walker V J Clin Pathol; 2013 May; 66(5):426-31. PubMed ID: 23454727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]